Beow Y. Yeap

25.4k citations

206 papers · 14.4k indexed · 4 hit papers · h-index 68

Impact in

Pulmonary and Respiratory Medicine top 0.05%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Radiation Therapy and Dosimetry
- Brain Metastases and Treatment
Oncology top 0.1%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies

Papers in

Pulmonary and Respiratory Medicine 134
- Lung Cancer Treatments and Mutations 59
- Occupational and environmental lung diseases 22
- Lung Cancer Diagnosis and Treatment 19
Oncology 102
- Lung Cancer Research Studies 33
- Pancreatic and Hepatic Oncology Research 17
- Colorectal Cancer Treatments and Studies 17

Co-authors: Pasi A. Jänne Bruce E. Johnson Lucian R. Chirieac Alice T. Shaw A. John Iafrate Mari Mino–Kenudson David M. Jackman Thomas J. Lynch
Journals: Journal of Clinical Oncology (45 papers)International Journal of Radiation Oncology*Biology*Physics (27 papers)Clinical Cancer Research (18 papers)Cancer (16 papers)Journal of Thoracic Oncology (9 papers)
Partner nations: United States Canada China

In The Last Decade

Beow Y. Yeap

199 papers receiving 14.2k citations

Hit Papers

align trajectories log scale

Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma 2018 · 362 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2018 JAMA Oncology
2013 Clinical Cancer Research
2009 Journal of Clinical Oncology
2009 Clinical Cancer Research

Peers

Countries citing papers authored by Beow Y. Yeap

Since Specialization

Citations

This map shows the geographic impact of Beow Y. Yeap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beow Y. Yeap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beow Y. Yeap more than expected).

Fields of papers citing papers by Beow Y. Yeap

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beow Y. Yeap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beow Y. Yeap. The network helps show where Beow Y. Yeap may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Beow Y. Yeap, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Beow Y. Yeap Line = papers co-authored together Beow Y. Yeap links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Circulating and Imaging Biomarkers of Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer JCO Precision Oncology ·Philip J. Saylor, Keisuke Otani, Trường Điện, Alexis Hope Sturdy, 이데 세이노스케, Rebecca Fisher, V. Srilekha, 韩雅如, Lütfiye Seçil Deniz Balyen, Matthew R. Smith, А. В. Гришко, G. Reis Mitermayer, Alarice Lowe, Mehmet Toner, Shyamala Maheswaran, Daniel A. Haber, Beow Y. Yeap, Richard J. Lee, David T. Miyamoto	2024	4
2	Phase I/II Investigator-Initiated Study of Olaparib and Temozolomide in SCLC: Final Analysis and CNS Outcomes Clinical Cancer Research ·Catherine B. Meador, Subba R. Digumarthy, Beow Y. Yeap, Yin P. Hung, Mari Mino–Kenudson, Anna F. Farago, Rebecca S. Heist, 乙彦加賀, Deepa Rangachari, David A. Barbie, Zofia Piotrowska	2024	1
3	Phase 2 Trial of Consolidative Stereotactic Body Radiation Therapy in Patients With Metastatic Oncogene-driven Non-small Cell Lung Carcinoma Treated With Tyrosine Kinase Inhibitors International Journal of Radiation OncologyBiologyPhysics ·Florence K. Keane, Beow Y. Yeap, Melin J. Khandekar, W. Marston Linehan, Ibiayi Dagogo‐Jack, Lecia V. Sequist, Zofia Piotrowska, Henning Willers	2024	0
4	Association of RERG Expression with Female Survival Advantage in Malignant Pleural Mesothelioma Cancers ·Assunta De Rienzo, Melissa H. Coleman, Beow Y. Yeap, David T. Severson, Benjamin Wadowski, Corinne E. Gustafson, Roderick V. Jensen, Lucian R. Chirieac, William G. Richards, Raphael Bueno	2021	7
5	Treatment with Next-Generation ALK Inhibitors Fuels Plasma ALK Mutation Diversity Clinical Cancer Research ·Ibiayi Dagogo‐Jack, Marguerite Rooney, W. Marston Linehan, Rebecca J. Nagy, Beow Y. Yeap, Harper Hubbeling, Emily Chin, Jennifer Ackil, Anna F. Farago, Aaron N. Hata, Jochen K. Lennerz, Justin F. Gainor, Richard B. Lanman, Alice T. Shaw	2019	112
6	Pencil Beam Scanning Proton Beam Chemoradiation Therapy With 5-Fluorouracil and Mitomycin-C for Definitive Treatment of Carcinoma of the Anal Canal: A Multi-institutional Pilot Feasibility Study International Journal of Radiation OncologyBiologyPhysics ·Jennifer Y. Wo, John P. Plastaras, James M. Metz, Wenqing Jiang, Beow Y. Yeap, Lorraine C. Drapek, Judith Adams, Christian Baglini, David P. Ryan, Janet E. Murphy, Aparna R. Parikh, Jill N. Allen, Jeffrey W. Clark, Lawrence S. Blaszkowsky, Thomas F. DeLaney, Edgar Ben‐Josef, Theodore S. Hong	2019	21
7	Impact of BRAF Mutation Class on Disease Characteristics and Clinical Outcomes in BRAF-mutant Lung Cancer Clinical Cancer Research ·Ibiayi Dagogo‐Jack, Pablo Martínez, Beow Y. Yeap, Chiara Ambrogio, Lorin A. Ferris, Christine Lydon, Tom Nguyen, Nicholas A. Jessop, A. John Iafrate, Bruce E. Johnson, Jochen K. Lennerz, Alice T. Shaw, Mark M. Awad	2018	80
8	Progression-Free and Overall Survival in ALK-Positive NSCLC Patients Treated with Sequential Crizotinib and Ceritinib Clinical Cancer Research ·Justin F. Gainor, Daniel Shao-Weng Tan, Annett Zaumüller, Benjamin Solomon, Michael Curry Harper, Chiara Lazzari, Filippo de Marinis, Gianluca Spitaleri, Katherine R. Schultz, Luc Friboulet, Beow Y. Yeap, Jeffrey A. Engelman, Alice T. Shaw	2015	135
9	Adapting a Drug Screening Platform to Discover Associations of Molecular Targeted Radiosensitizers with Genomic Biomarkers Molecular Cancer Research ·Qi Liu, Meng Wang, A. Barceló, Jan. Auteur ou responsable intellectuel Piwowarczyk, Jing Han, Beow Y. Yeap, Theodore S. Hong, Jeff Settleman, Cyril H. Benes, Kathryn D. Held, Jason A. Efstathiou, Henning Willers	2015	29
10	Preliminary Results of a Phase II Trial of Proton Radiotherapy for Pediatric Rhabdomyosarcoma Journal of Clinical Oncology ·Matthew Ladra, Jackie Szymonifka, Anita Mahajan, Alison M. Friedmann, Beow Y. Yeap, Lali Medina-Kauwe, Shannon M. MacDonald, David R. Grosshans, Carlos Rodríguez‐Galindo, Karen J. Marcus, Nancy J. Tarbell, Torunn I. Yock	2014	91
11	Clinical, Pathologic, and Biologic Features Associated with BRAF Mutations in Non–Small Cell Lung Cancer Clinical Cancer Research ·Stephanie Cardarella, Atsuko Ogino, Mizuki Nishino, Mohit Butaney, Jeanne Shen, Christine Lydon, Beow Y. Yeap, Lynette M. Sholl, Bruce E. Johnson, Pasi A. Jänne	2013	274
12	Sequential Binary Gene Ratio Tests Define a Novel Molecular Diagnostic Strategy for Malignant Pleural Mesothelioma Clinical Cancer Research ·Assunta De Rienzo, William G. Richards, Beow Y. Yeap, Melissa H. Coleman, 张志平, Lucian R. Chirieac, Yaoyu E. Wang, John Quackenbush, Roderick V. Jensen, Raphael Bueno	2013	17
13	Activation of PI3K Signaling in Merkel Cell Carcinoma Clinical Cancer Research ·Valentina Nardi, Youngchul Song, Juan A. Santamaria‐Barria, Arjola K. Cosper, Quynh Lam, Anthony C. Faber, Genevieve M. Boland, Beow Y. Yeap, Kristin Bergethon, M.H. Szwarcman, Hensin Tsao, Jeffrey Settleman, David P. Ryan, Darrell R. Borger, Atul K. Bhan, Mai P. Hoang, A. John Iafrate, James C. Cusack, Jeffrey A. Engelman, Dora Dias‐Santagata	2012	87
14	Donor Bone Marrow-Derived T Cells Inhibit GVHD Induced by Donor Lymphocyte Infusion in Established Mixed Allogeneic Hematopoietic Chimeras PLoS ONE ·Hui Wang, Yanping Yang, Guanjun Wang, Shu‐Mei Wang, Beow Y. Yeap, Megan Sykes, Yong‐Guang Yang	2012	2
15	IFN-γ promotes graft-versus-leukemia effects without directly interacting with leukemia cells in mice after allogeneic hematopoietic cell transplantation Blood ·Yanping Yang, Hui Wang, Hui Yu, Beow Y. Yeap, Tingting Liang, Guanjun Wang, Tao Cheng, Yong‐Guang Yang	2011	10
16	Met Activation in Non-Small Cell Lung Cancer Is Associated with de Novo Resistance to EGFR Inhibitors and the Development of Brain Metastasis American Journal Of Pathology ·Elisa Benedettini, Lynette M. Sholl, Michael Peyton, John F. Reilly, Christopher Ware, Lenora J. Davis, Natalie Vena, D. R. Shackleton Bailey, Beow Y. Yeap, Michelangelo Fiorentino, Azra H. Ligon, 薛殿凯, Victoria M. Richon, John D. Minna, Adi F. Gazdar, Giulio Draetta, Silvano Bòsari, Lucian R. Chirieac, Bart Lutterbach, Massimo Loda	2010	139
17	Unique Clinicopathologic Features Characterize ALK -Rearranged Lung Adenocarcinoma in the Western Population Clinical Cancer Research ·Scott J. Rodig, Mari Mino–Kenudson, Sanja Đačić, Beow Y. Yeap, Alice T. Shaw, Justine A. Barletta, Hannah Stubbs, Fitria Musannadah, Neal I. Lindeman, Eugene J. Mark, Pasi A. Jänne, Thomas J. Lynch, Bruce E. Johnson, A. John Iafrate, Lucian R. Chirieac Hit paper breakdown →	2009	526
18	Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK Journal of Clinical Oncology ·Alice T. Shaw, Beow Y. Yeap, Mari Mino–Kenudson, Subba R. Digumarthy, Daniel B. Costa, Rebecca S. Heist, Benjamin Solomon, Hannah Stubbs, Sonal Admane, Ultan McDermott, Jeffrey Settleman, Susumu Kobayashi, Eugene J. Mark, Scott J. Rodig, Lucian R. Chirieac, Eunice L. Kwak, Thomas J. Lynch, A. John Iafrate Hit paper breakdown →	2009	1463
19	Exon 19 Deletion Mutations of Epidermal Growth Factor Receptor Are Associated with Prolonged Survival in Non–Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib Clinical Cancer Research ·David M. Jackman, Beow Y. Yeap, Lecia V. Sequist, Neal I. Lindeman, Alison J. Holmes, Victoria A. Joshi, Daphne W. Bell, Mark S. Huberman, Balázs Halmos, Michael S. Rabin, Daniel A. Haber, Thomas J. Lynch, Matthew Meyerson, Bruce E. Johnson, Pasi A. Jänne	2006	491
20	Validation of Genomics-Based Prognostic Tests in Malignant Pleural Mesothelioma Clinical Cancer Research ·Gavin J. Gordon, Graham N. Rockwell, Paul A. Godfrey, Roderick V. Jensen, Jonathan N. Glickman, Beow Y. Yeap, William G. Richards, David J. Sugarbaker, Raphael Bueno	2005	67

About Beow Y. Yeap

Beow Y. Yeap is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Genetics, Cancer Research and Hematology, having authored 206 papers that have together received 14.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (59 papers), Lung Cancer Research Studies (33 papers), Cancer Genomics and Diagnostics (23 papers), Occupational and environmental lung diseases (22 papers), Lung Cancer Diagnosis and Treatment (19 papers), Glioma Diagnosis and Treatment (18 papers), Pancreatic and Hepatic Oncology Research (17 papers) and Colorectal Cancer Treatments and Studies (17 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (10.3k citations), Oncology (7.1k citations), Cancer Research (2.2k citations), Genetics (1.4k citations) and Radiation (822 citations). Beow Y. Yeap has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Pasi A. Jänne, Bruce E. Johnson, Lucian R. Chirieac, Alice T. Shaw, A. John Iafrate, Mari Mino–Kenudson, David M. Jackman, Thomas J. Lynch, Daniel B. Costa and Eugene J. Mark. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Clinical Cancer Research, Cancer and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact